These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29303385)

  • 1. Achromatopsia: clinical features, molecular genetics, animal models and therapeutic options.
    Hirji N; Aboshiha J; Georgiou M; Bainbridge J; Michaelides M
    Ophthalmic Genet; 2018 Apr; 39(2):149-157. PubMed ID: 29303385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy for Achromatopsia.
    Baxter MF; Borchert GA
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achromatopsia: on the doorstep of a possible therapy.
    Zobor D; Zobor G; Kohl S
    Ophthalmic Res; 2015; 54(2):103-8. PubMed ID: 26304472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cone dysfunction syndromes.
    Aboshiha J; Dubis AM; Carroll J; Hardcastle AJ; Michaelides M
    Br J Ophthalmol; 2016 Jan; 100(1):115-21. PubMed ID: 25770143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achromatopsia as a potential candidate for gene therapy.
    Pang JJ; Alexander J; Lei B; Deng W; Zhang K; Li Q; Chang B; Hauswirth WW
    Adv Exp Med Biol; 2010; 664():639-46. PubMed ID: 20238068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy for Color Blindness.
    Hassall MM; Barnard AR; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):543-551. PubMed ID: 29259520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia.
    Pang JJ; Deng WT; Dai X; Lei B; Everhart D; Umino Y; Li J; Zhang K; Mao S; Boye SL; Liu L; Chiodo VA; Liu X; Shi W; Tao Y; Chang B; Hauswirth WW
    PLoS One; 2012; 7(4):e35250. PubMed ID: 22509403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of cone vision in a mouse model of achromatopsia.
    Alexander JJ; Umino Y; Everhart D; Chang B; Min SH; Li Q; Timmers AM; Hawes NL; Pang JJ; Barlow RB; Hauswirth WW
    Nat Med; 2007 Jun; 13(6):685-7. PubMed ID: 17515894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.
    Yang P; Michaels KV; Courtney RJ; Wen Y; Greninger DA; Reznick L; Karr DJ; Wilson LB; Weleber RG; Pennesi ME
    JAMA Ophthalmol; 2014 Jul; 132(7):823-31. PubMed ID: 24676353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.
    Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B
    JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for achromatopsia.
    Michalakis S; Schön C; Becirovic E; Biel M
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28095637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene replacement therapy in achromatopsia type 2].
    Mühlfriedel R; Tanimoto N; Seeliger MW
    Klin Monbl Augenheilkd; 2014 Mar; 231(3):232-40. PubMed ID: 24658860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and Disease Expression in the CNGA3 Form of Achromatopsia: Steps on the Path to Gene Therapy.
    Zelinger L; Cideciyan AV; Kohl S; Schwartz SB; Rosenmann A; Eli D; Sumaroka A; Roman AJ; Luo X; Brown C; Rosin B; Blumenfeld A; Wissinger B; Jacobson SG; Banin E; Sharon D
    Ophthalmology; 2015 May; 122(5):997-1007. PubMed ID: 25616768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achromatopsia: a review.
    Remmer MH; Rastogi N; Ranka MP; Ceisler EJ
    Curr Opin Ophthalmol; 2015 Jul; 26(5):333-40. PubMed ID: 26196097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of tinted contact lenses in the management of achromatopsia.
    Schornack MM; Brown WL; Siemsen DW
    Optometry; 2007 Jan; 78(1):17-22. PubMed ID: 17208670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Treatment Options for Achromatopsia: A Review of the Literature.
    Pascual-Camps I; Barranco-Gonzalez H; Aviñó-Martínez J; Silva E; Harto-Castaño M
    J Pediatr Ophthalmol Strabismus; 2018 Mar; 55(2):85-92. PubMed ID: 29257187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Achromatopsia].
    Poloschek CM; Kohl S
    Ophthalmologe; 2010 Jun; 107(6):571-80; quiz 581-2. PubMed ID: 20533046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achromatopsia: the first case report in Thailand.
    Ruangvaravate N; Samsen P; Thuangtong A; Chanvarapha N
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S147-50. PubMed ID: 22696868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy in color vision deficiency: a review.
    El Moussawi Z; Boueiri M; Al-Haddad C
    Int Ophthalmol; 2021 May; 41(5):1917-1927. PubMed ID: 33528822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress on study of achromatopsia and targeted gene therapy].
    Dai XF; Pang JJ
    Zhonghua Yan Ke Za Zhi; 2012 Aug; 48(8):755-8. PubMed ID: 23141518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.